In this issue:
Finerenone reduces HF risk in patients with CKD and type 2 diabetes
Long-term follow-up of ICDs for nonischaemic systolic HF
Trends in US HF hospitalisations
Empagliflozin for HF across the LVEF spectrum
Treatment persistence of RAAS inhibitors over time in HFREF
Intermittent SVC occlusion to improve haemodynamics in acute decompensated HF
Complications and mortality following CRT-D vs. ICDs in elderly HF
HF risk and predictors in sarcoidosis
Temporal change in renoprotective effect of tolvaptan in HF
Please login below to download this issue (PDF)